TCIM
PETX
TIAA CREF Investment Management’s Aratana Therapeutics, Inc. PETX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | $904K | Sell |
251,088
-11,257
| -4% | -$40.5K | ﹤0.01% | 2370 |
|
2018
Q4 | $1.61M | Sell |
262,345
-28,896
| -10% | -$177K | ﹤0.01% | 2072 |
|
2018
Q3 | $1.7M | Sell |
291,241
-23,441
| -7% | -$137K | ﹤0.01% | 2207 |
|
2018
Q2 | $1.34M | Buy |
314,682
+168,722
| +116% | +$717K | ﹤0.01% | 2377 |
|
2018
Q1 | $644K | Buy |
145,960
+41,540
| +40% | +$183K | ﹤0.01% | 2639 |
|
2017
Q4 | $549K | Sell |
104,420
-32,444
| -24% | -$171K | ﹤0.01% | 2727 |
|
2017
Q3 | $839K | Sell |
136,864
-89,600
| -40% | -$549K | ﹤0.01% | 2605 |
|
2017
Q2 | $1.64M | Sell |
226,464
-10,583
| -4% | -$76.5K | ﹤0.01% | 2303 |
|
2017
Q1 | $1.26M | Sell |
237,047
-38,069
| -14% | -$202K | ﹤0.01% | 2402 |
|
2016
Q4 | $1.98M | Sell |
275,116
-65,853
| -19% | -$473K | ﹤0.01% | 2202 |
|
2016
Q3 | $3.19K | Buy |
340,969
+14,829
| +5% | +$139 | ﹤0.01% | 1890 |
|
2016
Q2 | $2.06M | Buy |
326,140
+186,591
| +134% | +$1.18M | ﹤0.01% | 2098 |
|
2016
Q1 | $770K | Buy |
139,549
+40,360
| +41% | +$223K | ﹤0.01% | 2612 |
|
2015
Q4 | $553K | Sell |
99,189
-52,153
| -34% | -$291K | ﹤0.01% | 2859 |
|
2015
Q3 | $1.28M | Sell |
151,342
-9,430
| -6% | -$79.8K | ﹤0.01% | 2420 |
|
2015
Q2 | $2.43M | Buy |
160,772
+943
| +0.6% | +$14.3K | ﹤0.01% | 2178 |
|
2015
Q1 | $2.56M | Buy |
159,829
+10,716
| +7% | +$172K | ﹤0.01% | 2071 |
|
2014
Q4 | $2.66M | Buy |
149,113
+35,608
| +31% | +$634K | ﹤0.01% | 2060 |
|
2014
Q3 | $1.14M | Buy |
113,505
+14,783
| +15% | +$148K | ﹤0.01% | 2559 |
|
2014
Q2 | $1.54M | Buy |
98,722
+76,262
| +340% | +$1.19M | ﹤0.01% | 2453 |
|
2014
Q1 | $417K | Buy |
22,460
+5,768
| +35% | +$107K | ﹤0.01% | 2988 |
|
2013
Q4 | $319K | Buy |
16,692
+1,590
| +11% | +$30.4K | ﹤0.01% | 3049 |
|
2013
Q3 | $247K | Buy |
+15,102
| New | +$247K | ﹤0.01% | 3039 |
|